We served as lead regulatory counsel to a private equity investment firm in its multi-billion dollar bid to take a publicly traded healthcare company private. Our team conducted regulatory due diligence and advised the private equity investment firm on the deal.
Private Equity Firm Takes Public Company Private
You Also May Be Interested In:
Represented Consonance Capital Partners in the recapitalization of Orsini Pharmaceutical Services, LLC
Represented CHS in its sale of Gulf Oaks Behavioral Hospital
Successfully represented a private equity backed portfolio provider and its management company in a voluntary disclosure to HHS-OIG involving improper billing